- 32,200$47B
1
- 11,322$5.3B
2
- 7,000$2.1B
3
- 5,353$2.3B
4
- 19,600$8.3B
5
- 40,000$13.5B
6
Astellas Pharma - Business Information
Manufacturing · Japan · 14,522 Employees
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.Read More
View Company Info for Free
Who is Astellas Pharma
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Top Competitors of Astellas Pharma
Astellas Pharma Org Chart
Astellas Pharma Email Formats
Astellas Pharma uses at least 5 email formats with first.last (ex. John.Smith@astellas.com) being used 81% of the time
Astellas Pharma Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@astellas.com | 81% |
first + last | JohnSmith@astellas.com | |
first_last | John_Smith@astellas.com | |
first | John@astellas.com | |
last | Smith@astellas.com |
Get Verified Emails
Astellas Pharma Company Metrics
$212.5M
Total Funding Amount
$75M
Most Recent Funding Amount
4
Number of Funding Rounds
Jul 15, 2021
Shaklee
Dec 17, 2020
IVERIC bio
Dec 08, 2018
Iota Biosciences
Jun 12, 2018
Ogeda
Jul 11, 2014
VESIcare
Dec 07, 2013
Euroscreen
See More Acquisitions & Subsidiaries
Astellas Pharma News & Media
Two-time Emmy® Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy (GA)
GA is a form of age-related macular degeneration (AMD) that causes irreversible vision loss, affecting approximately 1.5 million people in the United States1,2 Eric and his mother, Jamey, are sharing their family's story of GA and AMD to raise awareness of the disease NORTHBROOK, Ill.,...Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
GATHER2 24-month results met the primary objective of reducing the rate of GA growth in patients treated with IZERVAY compared to sham IZERVAY 24-month safety data were consistent with 12-month results, with no new safety signals identified TOKYO, Sept. 18, 2023 /PRNewswire/ -- Astellas...Astellas Venture Management and MBC BioLabs Announce the 5th Annual Astellas Future Innovator Prize
Awardees win a year of access to a prestigious life-science incubator in San Francisco, CA and to Astellas expertise to further their research Award helps biotech start-ups accelerate early drug discovery and research efforts TOKYO and SAN FRANCISCO, Sept. 18, 2023 /PRNewswire/ --...Genedata Collaborates with Astellas to Facilitate Regenerative Cell Therapy Product Development
Global pharmaceutical company implements Genedata Selector to automate the analysis of NGS-driven assays for adventitious agent detection during cell therapy development BASEL, Switzerland, Sept. 18, 2023 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software...
Frequently Asked Questions regarding Astellas Pharma
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.... Read More